Could a simple pill replace daily shots for blood clot prevention in cancer?

NCT ID NCT07270263

First seen Jan 03, 2026 · Last updated May 02, 2026 · Updated 18 times

Summary

This study looks at whether lower doses of two common blood thinner pills (apixaban and rivaroxaban) work as well as standard daily injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will be randomly assigned to one of three treatments and followed for 6 months. The goal is to find a safer, more convenient way to prevent clots without increasing bleeding risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Department of Haematology & Transplantology

    RECRUITING

    Gdansk, Pomeranian Voivodeship, 80-152, Poland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.